A careful analysis of the solubility, stability and other chemical properties of a newly discovered api will significantly streamline the. Stability in toxicology formulation 2. Standard buffer solutions described in the usp are considered to be appropriate for use in these studies.
pHSolubility profile of Raloxifene HCl Download
S s0 ph = pka + log s0 where s = overall solubility of the drug = concentration of ionized fraction + concentration of unionized fraction (su) for a weak base (bh+) the relationship between the.
Before a formulation is developed around an active pharmaceutical ingredient (api), that api itself must be clearly understood.
04/05/2012 kle college of pharmacy, nipani. Solubility /pka/ph solubility (when a drug substance is dissolved in a unit volume of liquid (solvent) to form a Thermal effects solubilization partition coefficient dissolution Derived preformulation properties are specific to the intended dosage form to be developed.
A clear understanding of a drug’s chemical properties will lead to a better formulation design.
Salt formation, partition or distribution coefficient, ph solubility profile and dissolution kinetics, permeability, solid state properties like polymorphism, stability profile etc. Preliminary preformulation can be carried out using in silico and experimental platforms to generate the preformulation profile of. Ph solubility profile and buffer compatibility Characterization of the active pharmaceutical ingredient (api) is critical to designing a successful formulation approach.
For solid dosage forms, solubility data are important in determining if an adequate amount of drug is available for absorption in vivo.
Two ionizable functions, with a pka1 value of 4.71 and a pka2 value of 8.94, produce the cationic and anionic forms, respectively. Approaches of increasing the solubility of drugs 1. Latitude’s preformulation services provide key information for formulating apis in solutions or solids. Solubility is one of the most important physicochemical properties studied during pharmaceutical preformulation.
For liquid dosage form development, accurate solubility data are essential to ensure the robustness of the finished product.
For compounds with ionisable groups this equilibrium solubility of the unionised form is known as the intrinsic solubility. By changing the ph of the solution for a weak acid the relationship between the ph of the solution and the solubility of the drug is: Corerx can evaluate the characteristics of your api, conduct small scale studies to understand key parameters around solubility and stability, and perform excipient compatibility studies to identify the right. Solution stability (a) ph stability profile 3.
Preformulation studies will start by measuring intrinsic solubility in a neutral, an acid and an alkaline environment;
By collecting and subsequently analyzing these important parameters, we can. Solubility should ideally be measured at two temperatures: If solubility is solubility.</strong> if solubility is preformulation</strong> study should be initiated. Typically 0.1 m hcl, water and 0.1 m naoh at 4 °c, 25 °c, 37 °c and an elevated temperature e.g.
Our solution phase program evaluates:
4°c to ensure physical stability. The important properties with reference to preformulation of parenterals includes solubility, pka, ph, solid state characteristics, chemical modification of drug and polymorphism etc. Stability analysis 5.1 preliminary stability evaluation 6.
